0001104659-24-043618.txt : 20240404
0001104659-24-043618.hdr.sgml : 20240404
20240404160346
ACCESSION NUMBER: 0001104659-24-043618
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20240404
DATE AS OF CHANGE: 20240404
EFFECTIVENESS DATE: 20240404
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: iBio, Inc.
CENTRAL INDEX KEY: 0001420720
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 262797813
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-509717
FILM NUMBER: 24823118
BUSINESS ADDRESS:
STREET 1: 600 MADISON AVENUE, SUITE 1601
CITY: NEW YORK
STATE: NY
ZIP: 10022-1737
BUSINESS PHONE: 302 355-0650
MAIL ADDRESS:
STREET 1: 600 MADISON AVENUE, SUITE 1601
CITY: NEW YORK
STATE: NY
ZIP: 10022-1737
FORMER COMPANY:
FORMER CONFORMED NAME: iBioPharma, Inc.
DATE OF NAME CHANGE: 20080806
FORMER COMPANY:
FORMER CONFORMED NAME: InB:Biotechnologies, Inc.
DATE OF NAME CHANGE: 20071210
D
1
primary_doc.xml
X0708
D
LIVE
0001420720
iBio, Inc.
8800 HSC PARKWAY
BRYAN
TX
TEXAS
77807
(979) 446-0027
DELAWARE
None
iBioPharma, Inc.
InB:Biotechnologies, Inc.
Corporation
true
Martin
Brenner
8800 HSC Parkway
Bryan
TX
TEXAS
77807
Executive Officer
Felipe
Duran
8800 HSC Parkway
Bryan
TX
TEXAS
77807
Executive Officer
Evert
Shimmelpennink
8800 HSC Parkway
Bryan
TX
TEXAS
77807
Director
Linda
Armstrong
8800 HSC Parkway
Bryan
TX
TEXAS
77807
Director
Alexandra
Kropotova
8800 HSC Parkway
Bryan
TX
TEXAS
77807
Director
William
Clark
8800 HSC Parkway
Bryan
TX
TEXAS
77807
Director
Gary
Sende
8800 HSC Parkway
Bryan
TX
TEXAS
77807
Director
James
Hill
8800 HSC Parkway
Bryan
TX
TEXAS
77807
Director
Biotechnology
Decline to Disclose
- 06b
false
2024-03-26
false
true
true
true
Warrants and Pre-Funded Warrants
false
0
Chardan Capital Markets LLC
000120128
None
None
17 State Street, Suite 2130
New York
NY
NEW YORK
10020
GA
GEORGIA
MA
MASSACHUSETTS
NY
NEW YORK
TX
TEXAS
PR
PUERTO RICO
false
15068745
15068745
0
false
8
794124
true
0
0
true
While no offering proceeds are set aside for payments to named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers.
false
iBio, Inc.
/s/ Martin Brenner
Martin Brenner
Chief Executive Officer
2024-04-03